319 related articles for article (PubMed ID: 15764775)
21. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases.
Viallat JR; Rey F; Astoul P; Boutin C
Chest; 1996 Dec; 110(6):1387-93. PubMed ID: 8989050
[TBL] [Abstract][Full Text] [Related]
22. Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases.
Barbetakis N; Asteriou C; Papadopoulou F; Samanidis G; Paliouras D; Kleontas A; Lyriti K; Katsikas I; Tsilikas C
J Cardiothorac Surg; 2010 Apr; 5():27. PubMed ID: 20403196
[TBL] [Abstract][Full Text] [Related]
23. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions.
Hartman DL; Gaither JM; Kesler KA; Mylet DM; Brown JW; Mathur PN
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):743-7; discussion 747-8. PubMed ID: 7682268
[TBL] [Abstract][Full Text] [Related]
24. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.
Fitzgerald DB; Sidhu C; Budgeon C; Tan AL; Read CA; Kwan BCH; Smith NA; Fysh ET; Muruganandan S; Saghaie T; Shrestha R; Badiei A; Nguyen P; Burke A; Goddard J; Windsor M; McDonald J; Wright G; Czarnecka K; Sivakumar P; Yasufuku K; Feller-Kopman DJ; Maskell NA; Murray K; Lee YCG
Trials; 2022 Jun; 23(1):530. PubMed ID: 35761341
[TBL] [Abstract][Full Text] [Related]
25. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
26. Talc pleurodesis for the management of malignant pleural effusions in Japan.
Inoue T; Ishida A; Nakamura M; Nishine H; Mineshita M; Miyazawa T
Intern Med; 2013; 52(11):1173-6. PubMed ID: 23728550
[TBL] [Abstract][Full Text] [Related]
27. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
[TBL] [Abstract][Full Text] [Related]
28. An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion.
Beck TN; Deneka AY; Chai L; Kanach C; Johal P; Alvarez NJ; Boumber Y; Golemis EA; Laub GW
BMC Cancer; 2019 Jun; 19(1):614. PubMed ID: 31234819
[TBL] [Abstract][Full Text] [Related]
29. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial.
Keeratichananont W; Kaewdech A; Keeratichananont S
Ther Adv Respir Dis; 2018; 12():1753466618816625. PubMed ID: 30526440
[TBL] [Abstract][Full Text] [Related]
31. Rapid pleurodesis for malignant pleural effusions: a pilot study.
Reddy C; Ernst A; Lamb C; Feller-Kopman D
Chest; 2011 Jun; 139(6):1419-1423. PubMed ID: 20930006
[TBL] [Abstract][Full Text] [Related]
32. Management of recurrent malignant pleural effusion with chemical pleurodesis.
Kilic D; Akay H; Kavukçu S; Kutlay H; Cangir AK; Enön S; Kadilar C
Surg Today; 2005; 35(8):634-8. PubMed ID: 16034542
[TBL] [Abstract][Full Text] [Related]
33. Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?
Terra RM; Junqueira JJM; Teixeira LR; Vargas FS; Pêgo-Fernandes PM; Jatene FB
Chest; 2009 Aug; 136(2):361-368. PubMed ID: 19349389
[TBL] [Abstract][Full Text] [Related]
34. The effect of silver nitrate pleurodesis after a failed thoracoscopic talc poudrage.
Menna C; Andreetti C; Ibrahim M; Maurizi G; Poggi C; Barile R; Cassiano F; Rendina EA
Biomed Res Int; 2013; 2013():295890. PubMed ID: 24073398
[TBL] [Abstract][Full Text] [Related]
35. Thoracoscopic talc pleurodesis for malignant pleural effusion.
Love D; White D; Kiroff G
ANZ J Surg; 2003; 73(1-2):19-22. PubMed ID: 12534732
[TBL] [Abstract][Full Text] [Related]
36. Pleurodesis for malignant pleural effusions.
Shaw P; Agarwal R
Cochrane Database Syst Rev; 2004; (1):CD002916. PubMed ID: 14973997
[TBL] [Abstract][Full Text] [Related]
37. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.
Janssen JP; Collier G; Astoul P; Tassi GF; Noppen M; Rodriguez-Panadero F; Loddenkemper R; Herth FJ; Gasparini S; Marquette CH; Becke B; Froudarakis ME; Driesen P; Bolliger CT; Tschopp JM
Lancet; 2007 May; 369(9572):1535-1539. PubMed ID: 17482984
[TBL] [Abstract][Full Text] [Related]
38. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial.
Haddad FJ; Younes RN; Gross JL; Deheinzelin D
World J Surg; 2004 Aug; 28(8):749-53; discussion 753-4. PubMed ID: 15457352
[TBL] [Abstract][Full Text] [Related]
39. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
[TBL] [Abstract][Full Text] [Related]
40. The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions.
Sahin U; Unlü M; Akkaya A; Ornek Z
Respiration; 2001; 68(5):501-5. PubMed ID: 11694813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
